Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation. [electronic resource]
Producer: 20150106Description: 1127-34 p. digitalISSN:- 1600-0641
- Acute-On-Chronic Liver Failure -- drug therapy
- Adult
- Antiviral Agents -- administration & dosage
- Drug Resistance, Viral -- genetics
- End Stage Liver Disease -- drug therapy
- Female
- Follow-Up Studies
- Genotype
- Guanine -- administration & dosage
- Hepatitis B virus -- genetics
- Hepatitis B, Chronic -- drug therapy
- Humans
- Lamivudine -- administration & dosage
- Male
- Middle Aged
- Multivariate Analysis
- Polymorphism, Restriction Fragment Length
- Predictive Value of Tests
- Prognosis
- Severity of Illness Index
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.